entertainment -WSS

entertainment

author：comprehensive 2025-10-01 02:27:29 - browse：9

A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT — A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

Next stop: Beacon Hill.

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： AstraZeneca stays mum on Medicare drug pricing negotiations

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

J&J lung cancer data amount to new salvo against AstraZeneca

Study on Amgen’s bispecific immunotherapy produces positive data

The CDC's new social media misinformation war

Problems with a popular proposal to regulate AI in health care

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

knowledge

entertainment

focus

In Memoriam: Notable people who died in 2023

A protest over insulin prices is seen as a fight for life

United colonoscopy coverage change 'may cost lives,' doctors say

CZI to create biohub to build anti

Drug repurposing or repositioning? The language matters

What’s missing from the debate over nursing home staff minimums

Continuity nursing helped my family in our darkest PICU moments

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Medicare proposal to cover medical devices draws a mixed reaction

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

focus

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Top private equity targets in 2023: cardiology, clinical trials, lasers

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Readout LOUD podcast: Live from the 2023 STAT Summit

Why Novartis is going to walk from its acquisition of MorphoSys

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

focus

explore

focus